Pasar al contenido principal

DESCODIFICACION DE LA ESPECIFICIDAD DEL SENSOR NEURONAL DE CALCIO 1 PARA DESARROLLAR COMPUESTOS MODULADORES DE SU INTERACCION EN APLICACIONES BIOTECNOLOGICAS Y TERAPEUTICAS

PID2019-111737RB-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2019
Plan Estatal 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 3
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

The neuronal calcium sensor NCS-1 regulates the phosphorylation state and activity of the Gα chaperone and GEF Ric-8A

  • Muñoz-Reyes, Daniel
  • McClelland, Levi J.
  • Arroyo-Urea, Sandra
  • Sánchez-Yepes, Sonia
  • Sabín, Juan
  • Pérez-Suárez, Sara
  • Menéndez, Margarita
  • Mansilla, Alicia
  • García-Nafría, Javier
  • Sprang, Stephen
  • Sánchez-Barrena, María José
36 pags., 8 figs.,, The neuronal calcium sensor 1 (NCS-1), an EF-hand Ca2+ binding protein, and Ric-8A coregulate synapse number and probability of neurotransmitter release. Recently, the structures of Ric-8A bound to Gα have revealed how Ric-8A phosphorylation promotes Gα recognition and activity as a chaperone and guanine nucleotide exchange factor. However, the molecular mechanism by which NCS-1 regulates Ric-8A activity and its interaction with Gα subunits is not well understood. Given the interest in the NCS-1/Ric-8A complex as a therapeutic target in nervous system disorders, it is necessary to shed light on this molecular mechanism of action at atomic level. We have reconstituted NCS-1/Ric-8A complexes to conduct a multimodal approach and determine the sequence of Ca2+ signals and phosphorylation events that promote the interaction of Ric-8A with Gα. Our data show that the binding of NCS-1 and Gα to Ric-8A are mutually exclusive. Importantly, NCS-1 induces a structural rearrangement in Ric-8A that traps the protein in a conformational state that is inaccessible to casein kinase II-mediated phosphorylation, demonstrating one aspect of its negative regulation of Ric-8A-mediated G-protein signaling. Functional experiments indicate a loss of Ric-8A guanine nucleotide exchange factor (GEF) activity toward Gα when complexed with NCS-1, and restoration of nucleotide exchange activity upon increasing Ca2+ concentration. Finally, the high-resolution crystallographic data reported here define the NCS-1/Ric-8A interface and will allow the development of therapeutic synapse function regulators with improved activity and selectivity., Spanish National Plan for Scientific and Technical Research and Innovation PID2019-111737RB-I00 Maria Jose Sanchez-Barrena Spanish National Plan for Scientific and Technical Research and Innovation PID2019-106608RB-I00 Alicia Mansilla Spanish National Plan for Scientific and Technical Research and Innovation PDC2022-133775-I00 Alicia Mansilla Spanish National Plan for Scientific and Technical Research and Innovation RTI2018-099985-B-I00 Margarita Menendez; Spanish National Plan for Scientific and Technical Research and Innovation PID2020-113359GA-I00 Javier García-Nafría; Spanish National Plan for Scientific and Technical Research and Innovation RYC-2017-22392 Alicia Mansilla; Spanish National Plan for Scientific and Technical Research and Innovation RYC2018-025731-I Javier García-Nafría National Institutes of Health P30GM140963 Stephen Sprang National Institutes of Health R01GM105993 Stephen Sprang, Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

FDA Drug Repurposing Uncovers Modulators of Dopamine D2 Receptor Localization via Disruption of the NCS-1 Interaction

  • Muñoz-Reyes, Daniel
  • Aguado, Lorena
  • Arroyo-Urea, Sandra
  • Requena, Carlos
  • Pérez-Suárez, Sara
  • Sánchez-Yepes, Sonia
  • Argerich, Josep
  • Miró-Rodríguez, Celia
  • Ulzurrun, Eugenia
  • Rodríguez-Martín, Eulalia
  • García-Nafría, Javier
  • Campillo, Nuria E.
  • Mansilla, Alicia
  • Sánchez-Barrena, María José
Dopamine D2 receptor (D2 R) regulates key aspects of motor control, cognition, and reward. Its function depends not only on ligand binding and signaling efficacy but also on the dynamic control of receptor localization at the cell surface. Neuronal calcium sensor 1 (NCS-1) interacts with D2 R in a Ca2+ -dependent manner. Using in vitro and cellular assays, we found that NCS-1 promotes D2 R trafficking to the plasma membrane through active exocytosis while preserving canonical receptor pharmacology. A screen of FDA-approved drugs identified protein–protein interaction (PPI) modulators targeting the NCS-1/D2 R interface. Azilsartan medoxomil, atorvastatin, and vilazodone disrupt this interaction, reducing D2 R surface expression. Structural studies revealed that these compounds target NCS-1, overlap the D2 R binding site, and perturb the dynamics of the regulatory helix H10. These findings reveal an unexploited intracellular mechanism to modulate D2 R function via PPI modulation, offering a novel strategy to fine-tune dopaminergic tone beyond receptor blockade or direct agonism., This work was supported by grants PID2019-111737RB-I00 and PID2022-137331OB-C31 (to M.J.S.B.); PID2020 113359GA-I00 and PID2023-148739NB-I00 (to J.G.N.);PID2022-137331OB-C32 (to A.M.); PID2022-137331OB-C33 (to N.E.C.); and the Spanish “Ramón y Cajal” program (to J.G.N. and A.M.), which were funded by the MICIU/AEI/ 10.13039/501100011033, FEDER and EU. S.P.S. was supported by a contract from the “Programa de Empleo Juvenil de la Comunidad de Madrid” PEJ-2020-AI/BMD 18666 and CMR by a Spanish National Research Council JAE Intro grant (JAEINT_23_00101)., Peer reviewed
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

FDA Drug Repurposing Uncovers Modulators of Dopamine D<sub>2</sub> Receptor Localization via Disruption of the NCS-1 Interaction

  • Muñoz-Reyes, Daniel
  • Aguado, Lorena
  • Arroyo-Urea, Sandra
  • Requena, Carlos
  • Pérez-Suárez, Sara
  • Sánchez-Yepes, Sonia
  • Argerich, Josep
  • Miró-Rodríguez, Celia
  • Ulzurrun, Eugenia
  • Rodríguez-Martín, Eulalia
  • García-Nafría, Javier
  • Campillo, Nuria E.
  • Mansilla, Alicia
  • Sánchez-Barrena, María José
Dopamine D2 receptor (D2R) regulates key aspects of motor control, cognition, and reward. Its function depends not only on ligand binding and signaling efficacy but also on the dynamic control of receptor localization at the cell surface. Neuronal calcium sensor 1 (NCS-1) interacts with D2R in a Ca2+-dependent manner. Using in vitro and cellular assays, we found that NCS-1 promotes D2R trafficking to the plasma membrane through active exocytosis while preserving canonical receptor pharmacology. A screen of FDA-approved drugs identified protein–protein interaction (PPI) modulators targeting the NCS-1/D2R interface. Azilsartan medoxomil, atorvastatin, and vilazodone disrupt this interaction, reducing D2R surface expression. Structural studies revealed that these compounds target NCS-1, overlap the D2R binding site, and perturb the dynamics of the regulatory helix H10. These findings reveal an unexploited intracellular mechanism to modulate D2R function via PPI modulation, offering a novel strategy to fine-tune dopaminergic tone beyond receptor blockade or direct agonism.